Celik, H. Et Al. 2018. Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99. ONCOGENE , vol.37, no.16 , 2181-2196.

Celik, H., Sciandra, M., Flashner, B., Gelmez, E., Kayrakilogiu, N., Allegakoen, D. V., ... Petro, J. R.(2018). Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99. ONCOGENE , vol.37, no.16, 2181-2196.

Celik, Haydar Et Al. "Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99," ONCOGENE , vol.37, no.16, 2181-2196, 2018

Celik, Haydar Et Al. "Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99." ONCOGENE , vol.37, no.16, pp.2181-2196, 2018

Celik, H. Et Al. (2018) . "Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99." ONCOGENE , vol.37, no.16, pp.2181-2196.

@article{article, author={Haydar Celik Et Al. }, title={Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99}, journal={ONCOGENE}, year=2018, pages={2181-2196} }